These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12811834)

  • 1. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion.
    Zagzag D; Nomura M; Friedlander DR; Blanco CY; Gagner JP; Nomura N; Newcomb EW
    J Cell Physiol; 2003 Aug; 196(2):394-402. PubMed ID: 12811834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.
    Mabjeesh NJ; Post DE; Willard MT; Kaur B; Van Meir EG; Simons JW; Zhong H
    Cancer Res; 2002 May; 62(9):2478-82. PubMed ID: 11980636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
    Koga F; Tsutsumi S; Neckers LM
    Cell Cycle; 2007 Jun; 6(11):1393-402. PubMed ID: 17525527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.
    Corley KM; Taylor CJ; Lilly B
    J Cell Biochem; 2005 Dec; 96(5):971-85. PubMed ID: 16149050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells.
    Nomura M; Nomura N; Newcomb EW; Lukyanov Y; Tamasdan C; Zagzag D
    J Cell Physiol; 2004 Dec; 201(3):374-84. PubMed ID: 15389545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
    Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH
    Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.
    Suzuki H; Tomida A; Tsuruo T
    Oncogene; 2001 Sep; 20(41):5779-88. PubMed ID: 11593383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
    Schwock J; Geddie WR; Hedley DW
    Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.
    Yang J; Yang JM; Iannone M; Shih WJ; Lin Y; Hait WN
    Cancer Res; 2001 May; 61(10):4010-6. PubMed ID: 11358819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities.
    Le Boeuf F; Houle F; Huot J
    J Biol Chem; 2004 Sep; 279(37):39175-85. PubMed ID: 15247219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.
    Ochel HJ; Schulte TW; Nguyen P; Trepel J; Neckers L
    Mol Genet Metab; 1999 Jan; 66(1):24-30. PubMed ID: 9973544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
    Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
    J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
    Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
    Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells.
    Wang TC; Luo SJ; Lin CL; Chang PJ; Chen MF
    Clin Exp Metastasis; 2015 Jan; 32(1):73-81. PubMed ID: 25527128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
    Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
    Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
    Schulte TW; Neckers LM
    Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.